Inflammation Research

, Volume 45, Issue 2, pp 83–88 | Cite as

Role of endogenous sulphydryls and neutrophil infiltration in the pathogenesis of gastric mucosal injury induced by piroxicam in rats

  • J. R. Avila
  • C. Alarcón de la Lastra
  • M. J. Martín
  • V. Motilva
  • I. Luque
  • D. Delgado
  • J. Esteban
  • J. Herrerias
Original Research Papers


In the present report we studied the formation of severe gastric erosions produced in fasted rats by intragastric administration of piroxicam (PRX), an enolic acid-derived NSAID. The time course of gastric damage and the possible role of mucus secretion, endogenous sulphydryl compounds, changes of gastric vascular permeability and neutrophil infiltration in the development of PRX-induced gastric lesions were also investigated. PRX dose-dependently (1.25–20 mg/kg) caused acute gastric haemorrhagic erosion in the rat. The lesions increased with time until 9 hr after dosing. Mucus secretion did not change significantly with respect to the control group with 5, 10 and 20 mg/kg of PRX at different times (3 and 6 hours) of treatment. There was also no increase in the concentration of its components. In addition, oral pretreatment of the animals with PRX did not significantly change the amount of dye trapped in the stomach. In contrast, non-protein SH fraction was decreased after administration of PRX and MPO activity as an index of neutrophil infiltration was significantly increased. These results suggest that independently of the PRX dose, depletion of endogenous non-protein SH and neutrophil infiltration could play an important part in the pathogenesis of gastric mucosal injury induced by PRX.

Key words

NSAIDs Piroxicam Gastric ulcer Neutrophils Sulphydryl compounds 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol. Multicentre, doubleblind, placebo-controlled trial. Lancet 1988;2:1277–80.Google Scholar
  2. [2]
    Konturek SJ. Mechanism of gastroprotection. Scand J Gastroenterol 1990;25 Suppl. 174:15–7.Google Scholar
  3. [3]
    Mecarthy DM. Nonsteroidal anti-inflammatory drugs — the clinical dilemmas. Scand J Gastroenterol 1992;27 Suppl 174:9–12.Google Scholar
  4. [4]
    Wallace J. Non-steroidal antiinflammatory drug gastropathy and cytoprotection: pathogenesis and mechanisms re-examined. Scand J Gastroenterol 1992;22:3–8.Google Scholar
  5. [5]
    Konturek SJ, Brzozowski T, Stachura J, Dembinski A, Malka J. Role of gastric blood flow, neutrophil infiltration in gastric adaptation to aspirin in the rat. Gut 1994;35:1189–96.Google Scholar
  6. [6]
    Guth P. Current concepts in gastric microcirculatory pathophysiology. Yale J Biol Med 1992;65:677–88.Google Scholar
  7. [7]
    Jacobson ED. Circulatory mechanisms of gastric mucosal damage and protection. Gastroenterology 1994;102:1788–800.Google Scholar
  8. [8]
    Allen A, Flemström G, Garner A, Kivilaakso F. Gastroduodenal mucosal protection. Physiol Rev 1993;73:823–27.Google Scholar
  9. [9]
    Shoen RT, Vender RJ. Mechanisms of nonsteroidal-anti-inflammatory drugs-induced gastric damage. Am J Med 1989;86:449–57.Google Scholar
  10. [10]
    Szabo S, Pihan G, Dupuy D. The biochemical pharmacology of sulphydryls compounds in gastric mucosal injury and protection. In: Szabo, S, Mózik G, editors. New Pharmacology of Ulcer Disease. New York: Elsevier, 1987:424–46.Google Scholar
  11. [11]
    Martin MJ, Marhuenda E, Alarcón de la Lastra C. Esculine, ranitidine and carbenoxolone: different modes of action on gastric mucosa. Gen Pharmac 1991;22:1001–4.Google Scholar
  12. [12]
    Lowry OH, Rosebrough NJ, Faar AL, Randall RJ. Protein measurement with the phenol reagent. J Biol Chem 1951;193:265–75.Google Scholar
  13. [13]
    Boas NF. Methods for determination of hexosamines in tissues. J Biol Chem 1953;204:553–66.Google Scholar
  14. [14]
    Garg GP, Cho CH, Ogle CW. The role of gastric mucosal sulphydryls in the ulcer-protecting effects of sulphasalazine. J Pharm Pharmacol 1991;43:733–4.Google Scholar
  15. [15]
    Sedlak J, Lindsay RH. Stimulation of total protein-bound and non-protein sulphydryls groups in tissue with Ellman's reagent. Am Biochem 1968;25:192–205.Google Scholar
  16. [16]
    Takeuchi K, Furukawa O, Nishiwaki H, Okabe S. 16,16-dimethyl prostaglandin E2 aggravates gastric mucosal injury induced by histamine in rats: possible role of the increased mucosal vascular permeability. Gastroenterology 1987,93:1276–88.Google Scholar
  17. [17]
    Ukada K, Takeuchi Y, Movat HZ. Simple method for quantification of enhanced vascular permeability. Proc Soc Exp Biol Med 1970;133:1276–88.Google Scholar
  18. [18]
    Grisham MB, Beniot JN, Granger DN. Assessment of leukocyte in involvement during ischemia and reperfusion on the intestine. In: Packer L, Glazer AN, editors. Methods in enzymology. Oxygen radicals in biological systems. San Diego: Academic Press, 1990;729–41.Google Scholar
  19. [19]
    Komatsu H, Koo A, Ghadisham E, Zeng H, Kuhlenkamp F, Inouue M, et al. Neutrophil accumulation in ischemic reperfused rat liver: evidence for a role for superoxide free radicals. Am J Physiol 1992;262:G669–76.Google Scholar
  20. [20]
    Brooks PM, Day RO. Nonsteroidal anti-inflammatory drugs defferences and similarities. N Engl J Med 1991;324:1716–25.Google Scholar
  21. [21]
    Meade EA, Smith WL, Dewitt DL. Expression of the murine prostaglandin (PGH) synthase-1 and PGH synthease-2-isoenzymes in cis-1 cells. J Lipid Mediat 1993;6:119–29.Google Scholar
  22. [22]
    Dewitt DL, Meade EA, Smith WL. PGH synthase selectivity: the potential for safer nonsteroidal antiinflammatory drugs. Am J Med 1993;95 suppl 2A:40S-4.Google Scholar
  23. [23]
    Szabo S, Vattay P. Experimental gastric and duodenal ulcers. Gastroenterol Clin N Am 1990;19:67–85.Google Scholar
  24. [24]
    Konturek PK, Brzozowski T, Konturek SJ, Dembinski A. Role of epidermal growth factor, prostaglandin and sulphydryls in stress-induced gastric lesions. Gastroenterology 1990;99:1607–15.Google Scholar
  25. [25]
    Yoshikawa T, Naito Y, Tomii T, Kaneko T, Iinuma S, Ichikawa H, et al. Role of active oxygen, lipid peroxidation and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 1993;34:734–7.Google Scholar
  26. [26]
    Wallace JL, Kennan CM, Granger ON. Gastric ulceration induced by non-steroidal antiinflammatory drugs is a neutrophil dependent process. Am J Physiol 1990;259 (Gastrointest Liver Physiol 22):G462–7.Google Scholar
  27. [27]
    Lee M, Aldred K, Lee E, Feldman M. Aspirin induced acute gastric mucosal injury is a neutrophil-dependent process in rats. Am J Physiol 1992;263 (Gastrointest Liver Physiol 16):G920–6.Google Scholar
  28. [28]
    Guth PH. Current concepts in gastric microcirculatory pathophysiology. Y J Biol Med 1992;65:677–88.Google Scholar
  29. [29]
    Wallace JL, Arfors KE, Mcknight GW. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 1991;100:878–83.Google Scholar
  30. [30]
    Andrews FJ, Malcontenti-Wilson C, O'Brien PE. Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am J Physiol 1994;266:G657–664.Google Scholar
  31. [31]
    Scheimer RP. The mechanisms of antiinflammatory steroid action in allergic diseases. Ann Rev Pharmacol Toxicol 1985;25:381–412.Google Scholar
  32. [32]
    Trevethick MA, Clayton NM, Strong P, Harman IW. Do infiltrating neutrophils contribute to the pathogenesis of indomethacin induced ulceration of the rat gastric antrum: Gut 1993;34:156–60.Google Scholar
  33. [33]
    Pihan G, Regillo C, Szabo S. Free radicals and lipid peroxidation in ethanol or aspirin-induced gastric mucosal injury. Dig Dis Sci 1987;32:1395–401.Google Scholar

Copyright information

© Birkhäuser Verlag 1996

Authors and Affiliations

  • J. R. Avila
    • 1
  • C. Alarcón de la Lastra
    • 1
  • M. J. Martín
    • 1
  • V. Motilva
    • 1
  • I. Luque
    • 1
  • D. Delgado
    • 1
  • J. Esteban
    • 1
  • J. Herrerias
    • 1
  1. 1.Laboratorio de Farmacodinamia, Departamento de Farmacia y Tecnología FarmacéuticaFacultad de FarmaciaSevillaSpain

Personalised recommendations